Page 191 - Genentech News Today

Operator: Greetings and welcome to the Matinas BioPharma 2022 Fourth Quarter and Full Year Conference Call. As a reminder, this conference is being recorded.

Budget committee will review Oregon effort to obtain some of the $52 billion available in federal money to encourage domestic manufacturing.

After claims of image manipulation in papers by Marc Tessier-Lavigne, neuroscientist promises vindication amid signs of faculty unease

A peptide drug conjugate is a type of drug molecule that combines a peptide with another molecule, such as a small molecule drug or a protein, to...

/PRNewswire/ -- BlackDoctor.org (BDO), the leading online health & wellness destination for Black consumers, announces the highly anticipated list of...

AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update Clinical-stage vaccine programs targeting amyloid-beta (Abeta), phosphorylated-Tau (pTau), and alpha-synuclein

AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update Clinical-stage vaccine programs targeting amyloid-beta (Abeta),...

For Companies That Care Day, check out the timeline and list of tech companies included. Learn more.

Backers say a new US law signals the beginning of the end of animal testing, while researchers predict that animal models will always be needed.

A conversation with Malcolm Harris about his new history of Silicon Valley, Palo Alto, the West Coast's settler ideology, and recent turbulence in the world of tech.